Reduced cholinergic function in the central nervous system contributes to memory disturbances, including those associated with senile dementia of the Alzheimer type. Previous studies by ourselves and others have demonstrated conclusively that distinct subtypes of muscarinic receptors are present in varying proportions in different brain regions. Classical receptor theory dictates that the most useful receptor classification schemes be based on the affinities of antagonists and several selective antagonists are now available (including pirenzepine, AF-DX 116, and quaternary antagonists). Past characterizations of muscarinic responses may have been confounded by tissue-related differences, as the different responses were studied in different tissues or preparations. This proposal intends to correlated sophisticated assays of binding and response in a model in vitro system, so as to relate the responses to given subpopulations. We will evaluate multiple muscarinic responses and receptor binding in parallel, in identical preparations (CNS neurons in primary culture); thereby, the problems of between-tissue differences will be eliminated and the affinities of a given antagonists in the different response assays and binding assays can be compared directly. The ability to generate neuronal cultures from regions of the brain that possess very different distributions of subpopulations will test the uniformity of the relationship between response and receptor subtype. The results of classical pharmacological methods, such as Schild analysis of competitive antagonists, will be supplemented by an independent procedure: selective protection of given subpopulation(s) of receptors from irreversible blockage by alkylating antagonists. Autoradiographic studies will determine whether subpopulations of muscarinic receptors are localized to specific types of (immunocytochemically identified) neurons. Studies of phosphorylation of muscarinic receptors are aimed at determining whether different subpopulations are differentially phosphorylated, desensitized, and down-regulated. The interactions of different kinases in regulating the sensitivity of the receptor(s) will also be investigated. It is expected that these studies will lead to a better understanding of the functions and regulation of different subpopulations of muscarinic receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG005214-06
Application #
3115770
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1985-02-01
Project End
1991-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
Schools of Medicine
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Shivnaraine, Rabindra V; Kelly, Brendan; Sankar, Krishana S et al. (2016) Allosteric modulation in monomers and oligomers of a G protein-coupled receptor. Elife 5:
Redka, Dar'ya S; Morizumi, Takefumi; Elmslie, Gwendolynne et al. (2014) Coupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptor. J Biol Chem 289:24347-65
Shivnaraine, Rabindra V; Huang, Xi-Ping; Seidenberg, Margaret et al. (2012) Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor. Biochemistry 51:4518-40
Stahl, Edward; Elmslie, Gwendolynne; Ellis, John (2011) Allosteric modulation of the M? muscarinic receptor by amiodarone and N-ethylamiodarone: application of the four-ligand allosteric two-state model. Mol Pharmacol 80:378-88
Stahl, Edward; Ellis, John (2010) Novel allosteric effects of amiodarone at the muscarinic M5 receptor. J Pharmacol Exp Ther 334:214-22
Prilla, Stefanie; Schrobang, Jasmin; Ellis, John et al. (2006) Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity. Mol Pharmacol 70:181-93
Huang, Xi-Ping; Prilla, Stefanie; Mohr, Klaus et al. (2005) Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phtha Mol Pharmacol 68:769-78
Trankle, Christian; Dittmann, Andreas; Schulz, Uwe et al. (2005) Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors. Mol Pharmacol 68:1597-610
Voigtlander, Uta; Johren, Kirstin; Mohr, Marion et al. (2003) Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupie Mol Pharmacol 64:21-31
Ford, Diane J; Essex, Anthony; Spalding, Tracy A et al. (2002) Homologous mutations near the junction of the sixth transmembrane domain and the third extracellular loop lead to constitutive activity and enhanced agonist affinity at all muscarinic receptor subtypes. J Pharmacol Exp Ther 300:810-7

Showing the most recent 10 out of 30 publications